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Graft-vers us-h ost disease (GVHD) can occur in bone m ar-
row-transplant recipients even when donor and host arc 
identically match ed at the m aj o r his toco mpatibility co m-
plex. GVHD in this context prest~m ab l y arises because of 
differences in mmor histocompatibiltty antigens. Munnc 
GVHD to minor his tocompatibility antigens has been stud-
ied in an effort to determine whether skin is a target of the 
immune response in thi s model system . T cell-deple ted 
marrow ce ll s (107) from BlO.BR (H-2k) mice were su p-
plemented with varying numbe rs of nylo n wool-enriched 
sple ni c B10.BR T cells and transplanted mtraven o usly mto 
irradiated (11 00 R) CB A (H-2k) mice. Sequential biopsies 
of ear sk in were obtained at weekly interva ls over a 7-week 
period. Histopathologic evaluation revealed basa l cell layer 
G raft-versus-host disease (GVHD) is a commonl y en-countered, frequently devasta ting co mpli cation of bone marrow transplantation (BMT). GVHD is thought to result from antigenic differences between host and donor cells, although the precise nature of 
the effector cells and their m olecul ar targets is unknown. The 
majority of hum an BMT occurs between donors and recipients 
who are identical at the m aJOr histocompatibdity complex (MHC), 
yet signifi cant numbers of these patients develop GVHD. GVHD 
in this context is presumed to result from differences 111 mmor 
histocompatibility antigens between donor and host. 
We have stud ied a murine model of GV HD to minor histo-
compatibility antigen differences that is clini ca ll y relevant to hu-
man disease. T he strain combinations employed (BlO.BR _,. CBA) 
have been shown to produce lethal GVHD with clini cal severity 
proportio nal to the number ofT lymphocytes added to the donor 
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vacuoli za tion, cxocytosis, and sa tellitos is of mononu clea r 
cell s in the epide rmis. Dyskeratosis was observed o nl y in 
animals receiving T ce ll s, and proved to be rhe mos t reli:-rblc 
hi sto log ic pa ra m ete r of disease w ith the number of dys-
keratotic cell s per linea r millimeter of e pidermis correlati ng 
both with sever ity of clini ca l disease and w ith th e number 
of tran splanted T cell s. Ultras tru c tural examination re-
vealed exocytosis of mononuclear cell s into the ep idermis 
where they were frequentl y apposed to degen eratin g an d 
n ecrotic keratinocy tes. These data in dicate th at t he skin is 
an info rmative target o rga n for study of experimenta l GVHD 
to minor hi stocompatibi lit y antigen s . J fnfl csr Ocnna/(J/ 
86:371-375, '1986 
m arrow inoculum [I]. Althou g h transp lant recipiems deve lo p 
pronounced signs ofGVJ-1]), in cl ud in g co pi ous diarrhea and weight 
loss, these findin gs arc not entirel y specifi c to GVHD and ca n 
occu r in immunocompromised and infected hosrs. Furtherm o re. 
cutaneo us alterations ha ve not been docum ented previous ly in 
rhis model despite the fact thar it has been srudi L·d in g reat derail 
[1]. This absence of skin d isease not onl y Ius raised questions 
about the clini ca l appl ica bility of thi s m odel, but ha s led ro rhe 
imp ress ion that GV HD of the skin OIIi y rarely occurs in th e m ou c 
[2J, lin1iring the use fulness of murin e m o,ic ls fo r studies of rh e 
pathogenesis of sk in GV HD ro min o r hisroco mparibiliry ami-
gens. T hi s study presents hi stologic ev id ence o f alteratio ns in th e 
skin of animals w irh clini ca l signs of GV HD th at bea r a strikin g 
sim ibri ty to the lesions described in hum an d isease. We co nclu de 
that in this model, as in other murim: m odel s, acute skin G VHD 
directed against min o r histocompatibilit y antigens is present and 
is li kely to be demonstrable in the m ajo rity of model syste ms 
despite minim al m acroscopic ev idence of d isease. 
MATEIUALS AND METHODS 
Marrow Harvesting and Treatment with Monoclonal An-
tibody and Complement B 10. B R (H-2') mi ce we re sacri ficed 
by cervical dislocation. Femurs and 1ibias were removed sur-
gica ll y and Rushed with Eagle's minimal essential medium ro 
whi ch had been added 3'Yo prcscrcencd feta l ca lf serum , 2 mM 
1..-glut::~ minc, penicillin (100 J.Lg/ ml). and streptom ycin (10() J.Lg/ml). 
A suspension of 50 X 10" harvested bo ne m arrow ce lls was in-
cubated for 40 min at 4°C w irh I ml ofa n ri-Thy \.2 mo noclo nal 
antibody (New Engla nd Nuclear, Boston , Massachuse tts) ar a 
dilution ofJO - -' in LIS medium (M .A. 13ioproducts, Walkersville. 
Maryland) . The cel ls were then pelktcd. rhc supcrn.1ra nt dis-
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ca rded , and 1 ml of 10- 1 dilution of prescrecned low-toxic guinea 
pig o r rabbit complement was added. After 45 min at 3rC, th e 
cells were washed and a second treatment wi th antibody and 
complement was performed in an identi cal fa shion. Finall y, th e 
anti-Th y 1. 2 and co mplement-treated marrow was was hed twi ce 
in L15. T he effectiveness ofT-cell rem ova l was determined by 
the inabil ity o f treated marrow tO react to all oanti gcns after 5 
days in a mi xed lymphocyte cul ture (sec below). Spleni c cel l 
suspensions from these same anim ~ l s were passed over nylon 
wool co lu mns to obta in a lymphocyte po pu lation enriched fo r T 
cell s (> 95% T cel ls by Au o rcsccncc activated cell so rte r; FACS). 
Irradiation and Reconstitution C BA (H-2k) mice were lc-
tlu ll y irradiated with ;1 137Cs source (gamma ce ll 40, Aromic 
Energy o f Canada, Ottawa, Canada) at 11 00 R in a split dose 
sepa rated by 3 h to avoid gastrointestinal toxi city. G roups of 
10-1 2 m icc were transplanted by intravenous injection of 10 X 
10'' l310. l:lR bone marrow cells w hi ch had been dep leted ofT 
cells, and to w hi ch increas in g numbers (0. 1 X 106, 2 X 106, 107) 
of nylon woo l-enri ched , B1 0.13 R spleni c T cells had been added. 
Tra nsplanted anim als received tetracycline hydrochl oride (8°/., 
solu tion) in their drinki ng water for the first 2 weeks posttrans-
plant. Control animals, irradiated and not transplanted (inocu-
lated w ith sa line), were maintained identi ca ll y. T he transplant 
regim en is precisely th at used by Korn gold and Sprent Ill w ith 
the exception that this ra d iation dose is slight ly hi gher. 
Generation and Assay of Cytotoxic Effector Cells In 
Vitro Bone marrow ce lls (5 X 10r') fro m donor J310.BR mice 
were cocul tivatcd w ith 5 X 101' irradiated (1500 R) all ogeneic 
(BALJ3 /c: H-2J) spleen cells for 5 da ys in 16-mm diameter culture 
wells (Linbro C hemica l Co ., Hamden , Connecticut) in 2 ml com-
plete cul ture medium. Complete culture medium consisted of 
RPM ! 1640 supplem ented w ith 10'Yo F S, 2 mM L-glu tam ine, 
5 X 10 5 M2-mercriptoethanol, peni cillin (10() J.Lg/ml) , and strep-
tomycin (100 J.Lg/ ml). After 5 da ys' culture at 3TC in a 5% C02 
80 
Untreated Marrow 
20 Treated Marrow+0. 1~T Cella 
Treated Marrow 
6 24 96 
E:T Ratio 
Figure 1. Elimination ofT cells from dono r marrow by anti-Th y 1. 2 
and co mplement trea tment. Untre;Jtcd (• ) and trea ted (e ) C57BL/6 
(H-2h) marrow were placed in a 5-da y mi xed lymphocyte cultu re with 
151)() H irradiated 13ALB/c (H-2d) stimula to r splcn ocytcs. N ylon wool-
passa!-;ecl ll(> T ce ll s (S X IO') (0. 1 '}\, of to ta l culture) were <Jdclcd to o ne 
~rou p of trea ted marrow effe cto rs (0 ). Effecto rs were harvested o n day 
5 and tested a~ai n s r I'H 15 (H-2") targe ts. Specific lys is is measured as a 
fun ction o f cffector :ta r~e t rati o . Each poin t represents the mean of 3 
cx pcrin1 cnts. 
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Figure 2. Lethal GV HD to mino r hi stocommparibility an ti gens . Survi-
va l as a fun ction o fT cell dose. Day 0: 107 T cell-depleted (a8) B10.BR 
(H-2k) marrow is injected i. v. into irrad iated (1000 R) C BA (H-2k) mice. 
n = 10 mice/group. Additio ns to marrow: --107 T cells;--- 106 T 
ce ll s; --- 6 X 106 a8 "T" cell s; - - salinc contro l. 
environment, effecto r cell s were harves ted, washed, counted, and 
assayed fo r specific cyto lyti c act ivity in a 5 1Cr release assay . This 
assay was performed as described previously [2] w ith some m od-
ifi ca tions. BrieRy, 5 X 101' target cells (P815:H-2d) were labeled 
with 100 J.LC i Nal 1Cr04 (N ew Eng land Nuclear) fo r 90 min at 
37°C in complete culture medium . Labeled target cells were washed 
3 times and 104 cells were mixed w ith varying numbers of effector 
cells in 0.2 ml of complete medium in 96-we ll V-bottomed plates 
(Linbro). Supernatant was harvested to determine rad ioactivity 
released . The percentage of chro mium released was calculated as 
percent specifi c release: 5 1Cr released by immune cells - 5 1Cr 
released by no rmal cells/max imum 5 1C r released (with 1% de-
oxycholate) - 5 1C r released by normal cells. 
Tissue and Histopathologic Examination Serial biopsies o f 
car sk in were obtained at th e time of transplantation, sequentially 
every 4-8 days (average every 7 days) for 7 weeks, and at the 
time of dea th. Biopsies were fu ll thickn ess, measured 8 X 10 
mm, and were performed in alternating sides. Care was taken to 
sa mple skin not adjacent to prev ious hea ling surgica l wounds . 
T iss ue was im mediately immersed in 10% neutral buffered for-
ma li n, fix ed fo r at least 24 h, and processed for routine paraffm 
histology. Sections 6 J.L m thick and cut 40 J.LI11 apart were evaluated 
fo r the fol lowing parameters: maturation d isa rray, basal cell layer 
vacuoliza tion, number of dyskeratotic epidermal cells, number 
of lymphocy tes in dermis and epidermis, satellitosis of lympho-
cy tes about dyskeratot ic cell s, li chen planus-like changes, and 
sclcrodcrmoid changes. Dyskeratotic cell s were enumerated per 
linear mil li meter of epidermi s with the aid of an ocular g rid mi-
cro mete r. Total ep idermal length eva luated per biopsy specimen 
ave ra ged 40 mm ± 10 mm. 
Transmission Electron Microscopy The specimens for elec-
tron microsco py were minced into cubes ap proxima tely 1 mm 
sq uare , fixed in Karnovsky's II solution for 5 h, and rinsed with 
V O L. 86. N O. 4 APHI L I 'J8f> 
0. 1 M sodium cacodylate buffer (pH 7.4) fo r 2 h . Pos tfi xa tion 
was achieved with 2% osmium te troxide fo r 2 h; after 2 15-min 
rinses with 0. I M sodium cacod ylate buffer, the ti ssue was de-
h y drated in g raded ethan o l so lutions and embedded in an E pon-
Araldite mi xture. One mi cro m eter-thi ck secti ons were cut on a 
Porter Blum MT-2 ultrami cro tom e and stained with Giemsa re-
agent for light mi croscopy . Ultrathin secti ons subsequmtl y cut 
for electro n mi crosco py w ere stained w ith uranyl acetate and 
lea d citrate and examined with a JEO L J EM 100S electron mi-
c r oscope. 
RES ULTS 
Effectiveness of Marrow Treatment M arrow depleti on of T 
ce ll s was tes ted in a 5-d ::~y C TL 51 C r release assay . As shown in 
Fig 1, untreated marrow exhibited a vigo rous all ogeneic res ponse 
but trea ted m arrow show ed no killin g above backg round . even 
w h en cultured in the presence of conc::1na va lin A supern atant . 
Additio n of 0.1 'Yo T cell s to the treated m arrow at th e initi ::l ti on 
of the 5-da y culture produ ced small but specifi c lys is at hi gh 
effector to target rati os . Thus antibod y and complement trea t-
m e nt o f th e m arrow was able to eliminate a ll cy totox ic T lym-
p h ocytes and their precurso rs at leas t to the 0. I 'Yo level. 
Clinical Graft-Versus-Host Disease Fig 2A shows the sur-
v iva l curves fo r transplant recipients. T he g roup receiving a T 
cell-de pl eted m arrow inoculum suppl emented by I X l(f T cells 
h a d a m edi an surviv ::1 l time (M ST ) of 20 days, w hereas the g roup 
receivi ng 1 X 1 0'' T cell s had a M ST of g re::1 ter th an 70 da ys . 
T h e g ro up reccivin g T cell-depleted marrow alonc had IOU % 
surv iva l at 100 days . Animals in each g roup were wei ghed twi ce 
weekl y fo r th e firs t m onth posttransplant and then wcekl y (Fig 
28) . C lini ca l m anifes tatio ns of acute G V 1-1 I) included in ac ti vit y. 
r u fA ed fur , hun ched pos ture, ri nd co pio us di arrh ea; these signs 
co rrelated with w ei g ht loss. A comparison o f Fi g 2A and B shows 
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th at the seve rity of th ese signs reAects th e tempo of pos ttransplant 
mo rtality. 
Histologic Graft-Versus-Host Disease Ea r skin appea red 
s li ghtl y ro ughen ed in animals wi th cl ini cal G VHD . Th is w as no t 
a constant fmdin g, however, and d id no t reliably co rrelate w ith 
o thn clini ca l signs of disease. Hi sto log ic an alys is o f sequential 
ca r bio psics revea led focal prog ress ing to d iffus e basa l cell laye r 
hyperpl asia (increase of th e basa l cell la yer to m ore th an one ce ll 
in thi ckness). prog ressive basa l cell vacuo li za tion, epide rm al and 
fo lli cular dys keratosis (cellul ar degenerati on and death de fin ed by 
nu clea r py kn osis o r frag mentation and cyto plasmic hypc rcos i-
nophili a). epiderm al maturat ion disa rray [diso rderl y change in 
axis fro m verti ca l (basal cell ) to ho ri zontal (s tratum corn eum 
cell )]. and scant but increasing infiltrates of superficia l derm al 
mononuclear cell s during th e first 7 weeks of the di sease (F igs 3. 
4) . T hese changes were m ost strikin g durin g the second to thit·d 
weeks post-BMT and in animal s th at had received 1 X I 07 spleni c 
T cell s in the m arrow inoculum (Fig 4). In so me bio psies, pe-
riph eral ;Jgg rega ti on of intrae piderm al m ononu clea r ce ll s about 
dys kerato ti c keratinocy tes (satelli tos is) was obscrvcd . 
T he mos t easil y quantifi able hi stopath o logic alteratio n was ep-
iderm al and fo lli cul ar dys keratosis. The number of dys kerato ti c 
ce ll s per linear millimete r of ep idermi s co rrela ted w ith th e pres-
ence of clini ca l CV HD in all an imals studied (Fig 5). T he number 
o f dys keratotic cells peaked during th e second to thi rd weeks 
pos t-13M T in anim als w ith clini ca l G VHD . Contro l anim als re-
ceiv ing marrow bu t no T ce ll s occas ionall y showed small numbers 
of similar ce lls d urin g the fi rsr to second week pos t-B MT, pos-
sibly related to irradiati on . 
Electron Microscopy Sequ ential analys is revealed g radu al ac-
cumulati on o f mononu clear ce ll s in th e dermi s durin g the fi rst 2 
weeks pos t- 13M T. Focall y, these ce ll s fo rm ed small agg rega tes 
wi thin th e epidermis and hair fo lli cles w here they were frequcml y 
Figure 3. Histopa tho logy of cutaneous acute 
G VHD . Seria l ca r biopsies o f C JJ A mice 
transplanted wi th I O'' T ce ll-depicted n l lJ.I1 R 
m arrow ce ll s and 101' B'IO .I11 ~ T ce ll s. I f = 
Da y 0 (m agni fica ti on = x 40) tf/0, d18, d25, 
tf29 = da ys I 0, 18 . 25, ;md 29 pos tt ra nsplant. 
res pecti vely ( X 100). 
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Figure 4. H is top~th o l ogy o l· 1- J.Lm sec tions ( l(f T cells; d ~y 14) . Nu-
merous mononu clea r ce lls, so me in appositi on tO dyskeratotic basa l ke-
ratin ocy tcs. arc present in th e lowe r hall of th e ep ider mis ( X 250). 
apposed to d egene ra tin g and necro ti c ba sa l kcratin ocytes (Fig 6). 
Even tuall y this p rocess became w idesp n :ad, resultin g in d isrup-
ti o n ofi nte rccllul arjun cti o ns and co rre la tin g w ith the appea ran ce 
of basa l ce ll lay er vacuo li zat io n b y li g ht mi crosco p y. 
T he infiltra tin g m o no nu clea r ce ll s we n: of 2 types. T he f1rst 
was a large r his ti ocyte-lik e cL· ll (20-40 J.Lnl in dia m eter). that 
contai ned a ro und to ovo id nu cleu s and p llJgocy toscd m ate rial 
assoc iated w ith cy to pl as mi c lysoso m es. T hi s m ateria l was o ften 
co mposed of agg rega tes of to n ofi lam cnts deriv ed fr o m n ec ro ti c 
kcrat in ocy tcs. The second was a smalkr ly mphocyte-like ce ll 
(1 0-20 J.Lm ) co n ta inin g an info ld ed nu cleu s and scant co m plc-
mcm s of cy to pl as mi c o rga nelles. !3oth ce ll s we re o bserv ed in th e 
der mis and epidermis, a lth o ug h degen e rat io n and necros is o f ad -
jacem cells was observed on ly in the epiLkrmis and h air fol li cles. 
Langcrh an s ce ll s wne 11ot obsnved in b iops iL·s studi ed by elccrro n 
111 ic roscopy. 
DI SCUSS ION 
This study dcK liJn <.: Jll S th e occurren ce of hi sto log ic a ltera ti o ns 
chara cte ri s ti c of JClltc cutaneo us G VHD in a murin e m ode l of 
C VHJ) to min o r hi s to co lllp at ibili ry anti ge ns. Neithn g ross no r 
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Figure 5. D ys kcraroric cells as :1 11 index of cutaneous :~ cute CVI-ID. 
Lcilla ll y ir rad iated ( 11 ()1 1 I ~) C UA mice (n = 3 per group) we re tr :~ n s­
pla iJ ted w ith T cell-depleted H I (1.13H with the addition of noT cel ls (0T ), 
Ill' ' T ce ll s ( Ill' ' T). :1nd 107 T cell s ( 11 17 T ). Serial car bi ops ies we re 
exami ned by light Jllicroscopy and th e nul\lber of dyskerato tic ce ll s per 
linc:1r millim eter o f epi derm is (cc ll ~,/ nllll ) wnc counted. Total len gth of 
epidermis exa mined was 4(1 ± 10 mm /binpsy. 
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Figure 6. T ransmiss ion electron microscopy. A port io n of a necrotic 
knatin ocy tc (*) is associated w ith ~ nl ononuclc:lr cells ((/() w ithin the 
epid ermis (E). /) = dermis: lwr = 1.0 J.Lill. 
mi croscop ic a lte ra ti o n of anHe G VHD in th e s kin ha ve been 
pre viously d ocum ented in thi s c lini ca ll y rclcvallt and wel l-ch ar-
ac teri zed mu r in e m odel a lth o ug h skin C VHD was hte r described 
in simibr sys te lll s 13-S J. Macrosco pic sk in chan ges (includin <> 
a lopecia) were obse r ved in different m ode ls of GV HD w m ino~ 
hi stoco mpat ibili ty anti ge ns b y both Ibppapo rr et all 3 1 and H am-
il tO n e t a l 141. C h arl ey c t :II 16 1 and H a milto n and Pa rkm a n J71 
ha ve each published co rrcl a ti o ns of m acroscop ic an d microscopic 
analys is of ski n G VHD in H-2 id enti cal marrow-transp l::uH re-
cipi ents . No alo pecia was ev id en t duri n g c lini ca l G VHD in the 
p resent m o de l an d ma croscop ic sk in changes we rL· minim a l, yet 
hi sto log ic am lys is o f sequent ial ca r biops ies shows not o nl y that 
ca r skin is a re li able and access ible so urce of ti ss ue . but that th e 
ch an ges o fa cllr L' skin G VHD arc in deed in ev id en ce in thi s m odel 
syste m. Thus skin GV HD to min o r his tocompatibilit y antigen s 
is probab ly uni ve rsal in murin e sys te m s w hen loo ked for vv ith 
app rop ri a te hi s to logic techniques. 
The spe cifi c it y of cutan eo us histo p:tth o logic alterations in acute 
CVHI) ha s been qu es ti o ned JSI. We have o bsn ved his tologic 
chan ges simibr ro mild ac ute G VHD in hum an and murin e skin 
presum ab ly as a res ult ofp rct r:m spl ant co nditi o nin g regi m e n s [9]. 
In thi s m ot~ el , howeve r, the cxtcnr of epidnmal d a ma ge (num ber 
of d ys keratot ic ce ll s) was an impo rtant discriminatin g tca tu rc 
bet ween cutan eo us chan ges associated w ith clini ca l GV I:-ID and 
th ose o bse rved in co ntro l an im als. T he f1nding of large number 
of d yske rato ti c epiderma l cell s co rrela ted w ith the presen ce of 
m o n o nu clear ce ll infil trates in rh e supe rfi c ia l der mi s and ep idermis 
(Fi gs 3, 4), and dyskeratosi s has recen t ly been show n to co rrelate 
w ith severit y of di sease in an in vitro p red ict ive test for GV H D 
to min o r hi stoco mpatibility anti g ens 11 0 1. C cllubr necros is h a 
also proved to be a s ig ni fica n t index o f inunune-mediated ti ssue 
rL:jec ti o n i11 o rga ns o th e r than skin. such as in th e settin g o f ca rdia c 
transplantati o n 1111 . 
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U ltras tru ct urall y, we observed frequ ent apposition of mono-
nu clear cell s to degenerat ing o r d ying epiderm al and fo lli cular 
k e ratin ocy tes. This rese mbled "sa tellite cel l d ys keratosis," a phe-
nomenon well documented in expe rimental acute GV I-:ID 11 2,1 31. 
Keratinocy tes sho win g similar alterat ions were no t obse rved in-
d e pendent of appostion to n1 ononucl ca r cell s, suggestin g th at 
direct contact between th ese ce ll s (as opposed to re lease of a 
soluble Jy mphocyto tox in) m ay m ediate target cell kil lin g. We did 
not observe parti cipation of Lan gcrhans cell s in these cellul ar 
interactio ns, a find ing consistent w ith prev ious studies in our 
laborato ry o f human GVHD 191. 
This stud y de m onstrates that seq uential biopsy of murin e car 
skin is an effective wa y of m oni to rin g the h isto logic evo luti on of 
acute GVHD to min o r histocompatibility an tigens w here no m ac-
roscop ic di sease is rc3_di ly identi fiab le. T hi s murine sys tem allows 
fo r the produ cn on o t acute G VHD With sys tem1 c and cutaneo us 
manifestations th at arc proportional to the num ber of dono r splenic 
T cel ls added to the T ccll-dcplctcd m arrow inoculum . Mo rtality 
and weig ht loss arc no t specifi c fo r GV HD and th e findin g o f 
hi stopath o logic parametc_rs ? f di sease act ivity in the skin enhan ces 
the experimenta l utlhty o t th1s and o ther murme models o f G VHD . 
Dcte rmjnati o n o f the effects of dep letion of subsets of splenic T 
cells ad ded to the dono r inoculum and of immunotherapeutic 
s trateg ies to ab roga te acu te GV HD to min or hi stocompatib ilit y 
antigens is now poss ible using skin as an a ccessible target o rgan_ 
of stu dy. Final ly, because th1 s m odel nl ll ll l CS mos t settin gs o t 
human .BMT (MH C - matched dono r and recipient), it prov ides 
a n experimenta l se tt ing_ releva n t to the pathophys io logy and Jm-
m un o hi sropath o logy o t cutaneous G VH D 111 hum ans. 
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